Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c

Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.09, $0.05 better than the analyst estimate of $2.04. Revenue for the quarter came in at $1.98 billion versus the consensus estimate of $1.96 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2016 EPS of $7.80-$7.95, versus the consensus of $7.81.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Edible Garden AG (EDBL) Reports Q2 Loss of $18.79
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M